Clinical trials for rectal cancer

53 currently recruiting clinical trials

Phase 2 Colon cancer Rectal cancer
#NCT05489211
Locally Advanced Metastatic 1 2 3 or more
Antibody Drug Conjugates (ADC) Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux)
AstraZeneca
Phase 2 Prostate cancer Colon cancer Rectal cancer Anal cancer Pancreas cancer
#NCT06333314
Neuroendocrine tumor MSI/dMMR Systemic Treatment-Naive
Immunotherapy Radiotherapy
Hôpital Henri-Mondor AP-HP (Créteil), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Hôpital Saint Antoine AP-HP (Paris)
UNICANCER
Phase 1 / Phase 2 Colon cancer Rectal cancer
#NCT03093116
Metastatic NTRK-1/2/3 ROS-1 1 2 3 or more Immunotherapy Chemotherapy
Systemic Treatment-Naive Targeted therapy
Centre Antoine Lacassagne (Nice), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Gustave Roussy (Villejuif)
Turning Point Therapeutics, Inc.
Phase 1 / Phase 2 Colon cancer Rectal cancer
#NCT03093116
Metastatic NTRK-1/2/3 1 2 3 or more Targeted therapy
Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Gustave Roussy (Villejuif)
Turning Point Therapeutics, Inc.
Phase 1 / Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer
#NCT06162221
Locally Advanced Metastatic KRAS G12C
Systemic Treatment-Naive Systemic Treatment-Naive
Hôpital Foch (Suresnes), Centre François Baclesse (Caen ), IUCT Oncopôle (Toulouse), Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ) (and 4 more...)
Revolution Medicines, Inc.
Phase 1 / Phase 2 Breast cancer Lung cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer
#NCT04104776
Urothelial carcinoma Locally Advanced Metastatic ARID1A 1 2 3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 1 / Phase 2 Colon cancer Rectal cancer
#NCT05706129
Locally Advanced Metastatic 1 2 3 or more Chemotherapy Targeted therapy
Centre Hospitalier Universitaire de Grenoble (La Tronche), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Universitaire de Nantes (Nantes), IUCT Oncopôle (Toulouse) (and 3 more...)
Debiopharm International SA
Phase 1 / Phase 2 Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Centre Hospitalier Universitaire de Nîmes (Nîmes), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 4 more...)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Colon cancer Rectal cancer Liver and bile duct cancer
#NCT06596694
Adenocarcinoma Hepatocellular carcinoma Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Hôpital Beaujon (Clichy)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Colon cancer Rectal cancer
#NCT05592626
Locally Advanced Metastatic MSI/dMMR 1 2 3 or more
Systemic Treatment-Naive
Institut Curie - Paris (Paris), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Marengo Therapeutics, Inc.